Proteros Biostructures Achieve Milestone in Fragment-Based Protein Crystallography Collaboration

Complete the form below to unlock access to ALL audio articles.
Proteros biostructures GmbH has announced that the first milestone of their research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography has been successfully achieved, triggering the associate milestone payment.
In the collaboration, which started in June 2006, Proteros applies its target know-how, industrial process and proprietary Free Mounting System (FMS™) and Picodropper™ technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs to Bayer HealthCare. Under the terms of the agreement Proteros will also receive a copy of the jointly selected fragment library for its own use.
”We are pleased to proof that Proteros’ experience, has allowed delivery of valuable protein-fragment-structures to Bayer HealthCare within the envisioned time frame”, stated Torsten Neuefeind, Ph.D., Chief Executive Officer of Proteros.